Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice.

Kelly K, Hutchinson G, Nebenius-Oosthuizen D, Smith AJ, Bartsch JW, Horiuchi K, Rittger A, Manova K, Docherty AJ, Blobel CP.

Dev Dyn. 2005 Jan;232(1):221-31.

2.

Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma.

King NE, Zimmermann N, Pope SM, Fulkerson PC, Nikolaidis NM, Mishra A, Witte DP, Rothenberg ME.

Am J Respir Cell Mol Biol. 2004 Sep;31(3):257-65.

PMID:
15087305
3.

Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration.

Schlomann U, Rathke-Hartlieb S, Yamamoto S, Jockusch H, Bartsch JW.

J Neurosci. 2000 Nov 1;20(21):7964-71.

4.

Potential role for ADAM15 in pathological neovascularization in mice.

Horiuchi K, Weskamp G, Lum L, Hammes HP, Cai H, Brodie TA, Ludwig T, Chiusaroli R, Baron R, Preissner KT, Manova K, Blobel CP.

Mol Cell Biol. 2003 Aug;23(16):5614-24.

5.

Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.

Sriraman V, Eichenlaub-Ritter U, Bartsch JW, Rittger A, Mulders SM, Richards JS.

Biol Reprod. 2008 Jun;78(6):1038-48. doi: 10.1095/biolreprod.107.066340.

6.

Deficiency of the metalloproteinase-disintegrin ADAM8 is associated with thymic hyper-cellularity.

Gossens K, Naus S, Holländer GA, Ziltener HJ.

PLoS One. 2010 Sep 15;5(9):e12766. doi: 10.1371/journal.pone.0012766.

7.

ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.

Guaiquil VH, Swendeman S, Zhou W, Guaiquil P, Weskamp G, Bartsch JW, Blobel CP.

J Mol Med (Berl). 2010 May;88(5):497-505. doi: 10.1007/s00109-010-0591-8.

8.

Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8).

Zack MD, Melton MA, Stock JL, Storer CE, Barve RA, Minnerly JC, Weiss DJ, Stejskal JA, Tortorella MD, Turk JR, Shevlin KM, Malfait AM.

Clin Exp Immunol. 2009 Nov;158(2):246-56. doi: 10.1111/j.1365-2249.2009.04009.x.

9.

ADAM8: a novel osteoclast stimulating factor.

Choi SJ, Han JH, Roodman GD.

J Bone Miner Res. 2001 May;16(5):814-22.

10.

[Expression of a disintegrin-like and metalloproteinase protein 8 and 12 in the giant cell lesions of jaw].

Meng XM, Yu SF.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2004 Jul;39(4):294-7. Chinese.

PMID:
15454013
11.

The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion.

Schlomann U, Wildeboer D, Webster A, Antropova O, Zeuschner D, Knight CG, Docherty AJ, Lambert M, Skelton L, Jockusch H, Bartsch JW.

J Biol Chem. 2002 Dec 13;277(50):48210-9.

12.

Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection.

Bartsch JW, Wildeboer D, Koller G, Naus S, Rittger A, Moss ML, Minai Y, Jockusch H.

J Neurosci. 2010 Sep 8;30(36):12210-8. doi: 10.1523/JNEUROSCI.1520-10.2010.

13.

ADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice.

Mahoney ET, Benton RL, Maddie MA, Whittemore SR, Hagg T.

J Comp Neurol. 2009 Jan 10;512(2):243-55. doi: 10.1002/cne.21902.

14.

Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis.

He S, Ding L, Cao Y, Li G, Deng J, Tu Y, Wang B.

Med Oncol. 2012 Sep;29(3):2032-7. doi: 10.1007/s12032-011-0084-9.

PMID:
21983884
15.

Upregulation of ADAM8 in the airways of mice with allergic bronchial asthma.

Chiba Y, Onoda S, Hattori Y, Maitani Y, Sakai H, Misawa M.

Lung. 2009 May-Jun;187(3):179-85. doi: 10.1007/s00408-009-9145-7.

PMID:
19373511
16.
17.

ADAM8 as a novel serological and histochemical marker for lung cancer.

Ishikawa N, Daigo Y, Yasui W, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y.

Clin Cancer Res. 2004 Dec 15;10(24):8363-70.

18.

Roles of ADAM8 in elimination of injured muscle fibers prior to skeletal muscle regeneration.

Nishimura D, Sakai H, Sato T, Sato F, Nishimura S, Toyama-Sorimachi N, Bartsch JW, Sehara-Fujisawa A.

Mech Dev. 2015 Feb;135:58-67. doi: 10.1016/j.mod.2014.12.001.

19.

The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma.

Naus S, Blanchet MR, Gossens K, Zaph C, Bartsch JW, McNagny KM, Ziltener HJ.

Am J Respir Crit Care Med. 2010 Jun 15;181(12):1318-28. doi: 10.1164/rccm.200909-1396OC.

PMID:
20194813
20.

Adam8 limits the development of allergic airway inflammation in mice.

Knolle MD, Nakajima T, Hergrueter A, Gupta K, Polverino F, Craig VJ, Fyfe SE, Zahid M, Permaul P, Cernadas M, Montano G, Tesfaigzi Y, Sholl L, Kobzik L, Israel E, Owen CA.

J Immunol. 2013 Jun 15;190(12):6434-49. doi: 10.4049/jimmunol.1202329.

Items per page

Supplemental Content

Support Center